Detalles de la búsqueda
1.
Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03.
Br J Cancer
; 101(9): 1537-42, 2009 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-19862000
2.
Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells.
J Cell Biol
; 153(2): 263-72, 2001 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-11309408
3.
Photon emissions from rice cells elicited by N-acetylchitooligosaccharide are generated through phospholipid signaling in close association with the production of reactive oxygen species.
Plant Physiol Biochem
; 44(11-12): 901-9, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17123826
4.
Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer.
J Natl Cancer Inst
; 83(12): 855-61, 1991 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-1648142
5.
Randomized controlled study of adjuvant immunotherapy with Nocardia rubra cell wall skeleton for inoperable lung cancer.
Cancer Res
; 43(11): 5575-9, 1983 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-6616485
6.
Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study.
J Clin Oncol
; 14(5): 1649-55, 1996 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-8622084
7.
Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group.
J Clin Oncol
; 16(3): 1068-74, 1998 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-9508192
8.
Phase I/II study of vinorelbine, mitomycin, and cisplatin for stage IIIB or IV non-small-cell lung cancer.
J Clin Oncol
; 17(10): 3195-200, 1999 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-10506618
9.
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
J Clin Oncol
; 17(9): 2692-9, 1999 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-10561343
10.
Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group.
J Clin Oncol
; 13(4): 869-75, 1995 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-7707113
11.
Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer.
J Clin Oncol
; 12(8): 1547-52, 1994 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-8040666
12.
A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group.
J Clin Oncol
; 11(10): 1852-7, 1993 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-8410109
13.
Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group.
J Clin Oncol
; 16(6): 2126-32, 1998 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-9626212
14.
A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin.
J Clin Oncol
; 9(4): 606-13, 1991 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-1648597
15.
Originality benefit and difficulty of clinical research in the West Japan Lung Cancer Group.
Crit Rev Oncol Hematol
; 36(1): 9-12, 2000 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-10996519
16.
Small cell carcinoma of the lung and its histological origin. Report of a case.
Am J Surg Pathol
; 3(4): 343-51, 1979 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-231908
17.
A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group.
Lung Cancer
; 11(5-6): 385-91, 1994 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-7704495
18.
Critical factors for patient management.
Lung Cancer
; 42 Suppl 1: S7-8, 2003 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-14708515
19.
Consensus: the follow-up of the treated patient.
Lung Cancer
; 42 Suppl 1: S17-9, 2003 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-14708519
20.
Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disorders.
J Cancer Res Clin Oncol
; 117(5): 473-8, 1991.
Artículo
en Inglés
| MEDLINE | ID: mdl-1909700